Benitec Biopharma

BNTC

Börsenwert 283 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
26	26 Russell Investments Group London, United Kingdom	1,73 Mio. $	+151.590 $	+12.780	+11 %
27	27 UBS Group Zurich, Switzerland	1,68 Mio. $	+114.013 $	+9.612	+8 %
28	28 Citadel Advisors Miami, Florida	1,09 Mio. $	-1,07 Mio. $	-90.256	-53 %
29	29 Charles Schwab San Francisco, California	947.986 $	+111.973 $	+9.440	+15 %
30	LPC 30 Lion Point Capital New York	829.560 $	–	–	–
31	31 Bank of New York Mellon New York	803.616 $	+196.569 $	+16.572	+38 %
32	32 Atom Investors Austin, Texas	650.148 $	-45.928 $	-3.872	-7 %
33	33 Cantor Fitzgerald New York	624.297 $	–	–	–
34	34 Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong	603.518 $	+427.287 $	+36.023	+397 %
35	35 ADAR1 Capital Management Austin, Texas	535.200 $	+266.884 $	+22.500	+129 %
36	36 Nuveen Charlotte, North Carolina	379.176 $	-159.834 $	-13.475	-32 %
37	37 RhumbLine Advisers Boston, Massachusetts	351.108 $	+68.761 $	+5.797	+28 %
38	38 AQR Capital Management Greenwich, Connecticut	300.796 $	+266.658 $	+22.481	Neu
39	39 Deutsche Bank Frankfurt Am Main Ge, Germany	278.571 $	+8.517 $	+718	+4 %
40	40 Morgan Stanley New York	261.927 $	-114.985 $	-9.694	-33 %
41	41 T. Rowe Price Associates Baltimore, Maryland	248.000 $	+219.770 $	+18.528	Neu
42	42 Wells Fargo San Francisco, California	240.064 $	+129.255 $	+10.897	+155 %
43	43 Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada	230.136 $	–	–	–
44	44 Martingale Asset Management Boston, Massachusetts	216.087 $	+191.563 $	+16.150	Neu
45	45 Bank of America Charlotte, North Carolina	213.692 $	-16.665 $	-1.405	-8 %
46	46 MetLife Investment Management Whippany, New Jersey	206.373 $	+71.489 $	+6.027	+64 %
47	47 Quadrature Capital London, United Kingdom	205.664 $	-32.192 $	-2.714	-15 %
48	EC 48 EntryPoint Capital New York	201.342 $	-110.004 $	-9.274	-38 %
49	49 Longaeva Partners Chicago, Illinois	199.014 $	-1,31 Mio. $	-110.126	-88 %
50	PAP 50 Persistent Asset Partners Hong Kong	167.156 $	-68.963 $	-5.814	-32 %

Benitec Biopharma BNTC Börsenwert 283 Mio. $

Benitec Biopharma

BNTC

Börsenwert 283 Mio. $